✦ LIBER ✦
609 A Phase 1 Study of MEDI-573, an Investigational Monoclonal Antibody That Targets IGF-I and IGF-II: Safety, Pharmacokinetics, and Antitumor Activity in Adults with Advanced Solid Tumors
✍ Scribed by Haluska, P.; Menefee, M.E.; Plimack, E.R.; Rosenberg, J.E.; Northfelt, D.W.; LaVallee, T.; Huang, W.; Yu, X.Q.; Viner, J.L.; LoRusso, P.
- Book ID
- 122000198
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 79 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.